{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T20:25:43Z","timestamp":1785875143216,"version":"3.56.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.vaccine.2023.04.066","type":"journal-article","created":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T06:05:18Z","timestamp":1682921118000},"page":"3550-3555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Hematologic adverse events reported after COVID-19 vaccination in the Philippines: A national database study"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5624-5435","authenticated-orcid":false,"given":"Flordeluna Z.","family":"Mesina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances Alexandra D.","family":"Sapinoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy Ann V.","family":"De Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti Prerna M.","family":"Vaswani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Eryll S.","family":"Sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rizza Ann A.","family":"Oquendo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark Ryann A.","family":"Lirasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.04.066_b0005","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Accessed November 14, 2022. https:\/\/covid19.who.int."},{"key":"10.1016\/j.vaccine.2023.04.066_b0010","unstructured":"Department of Health. Covid-19 Tracker. Accessed November 17, 2022 https:\/\/doh.gov.ph\/covid19tracker."},{"key":"10.1016\/j.vaccine.2023.04.066_b0015","unstructured":"Food and Drug Administration Philippines. Emergency Use Authorization. Accessed November 18, 2022. https:\/\/www.fda.gov.ph\/list-of-fda-issued-emergency-use-authorization\/."},{"key":"10.1016\/j.vaccine.2023.04.066_b0020","unstructured":"Department of Health. Covid-19 Vaccination Dashboard. Accessed November 17, 2022. https:\/\/doh.gov.ph\/covid19-vaccination-dashboard."},{"key":"10.1016\/j.vaccine.2023.04.066_b0025","unstructured":"Food and Drug Administration Philippines. Reports of Suspected Adverse Reactions to COVID-19. November 17, 2022. https:\/\/www.fda.gov.ph\/wp-content\/uploads\/2022\/11\/Reports-of-suspected-adverse-reaction-to-COVID-19-vaccines-as-of-31-October-2022.pdf."},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.066_b0030","doi-asserted-by":"crossref","first-page":"e0000165","DOI":"10.1371\/journal.pgph.0000165","article-title":"COVID-19 vaccine brand hesitancy and other challenges to vaccination in the Philippines","volume":"2","author":"Amit","year":"2022","journal-title":"PLOS Glob Public Health"},{"key":"10.1016\/j.vaccine.2023.04.066_b0035","unstructured":"Castillo MRI, Mesina F, de Castro JAV, et al. COVID-19 Vaccination in Adult Patients with Hematologic Diseases. https:\/\/pcp.org.ph\/index.php\/covid-19-vaccines\/1232- philippine-college-of-hematology-and-transfusion-medicine-pchtm-review-of-hematologic-events-post covid-19-vaccination."},{"issue":"4","key":"10.1016\/j.vaccine.2023.04.066_b0040","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/ajh.26478","article-title":"COVID-19 vaccines and risks of hematological abnormalities: Nested case\u2013control and self-controlled case series study","volume":"97","author":"Sing","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.vaccine.2023.04.066_b0045","doi-asserted-by":"crossref","first-page":"E413","DOI":"10.1002\/ajh.26345","article-title":"SARS-CoV-2 vaccination in patients with autoimmune cytopenias: The experience of a reference center","volume":"96","author":"Fattizzo","year":"2021","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.vaccine.2023.04.066_b0050","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/ajcp\/aqab210","article-title":"COVID-19 and Immune-Mediated RBC Destruction: A Systematic Review","volume":"157","author":"Jacobs","year":"2022","journal-title":"Am J Clin Pathol"},{"issue":"4","key":"10.1016\/j.vaccine.2023.04.066_b0055","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/imm.13443","article-title":"New-onset autoimmune phenomena post-COVID-19 vaccination","volume":"165","author":"Chen","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/j.vaccine.2023.04.066_b0060","article-title":"Development and exacerbation of autoimmune hemolytic anemia following COVID -19 vaccination: A systematic review","author":"Jafarzadeh","year":"2022","journal-title":"Int J Lab Hematol"},{"issue":"9","key":"10.1016\/j.vaccine.2023.04.066_b0065","first-page":"572","article-title":"A narrative review of anti-SARS-CoV-2 vaccines and immune thrombocytopenia: be aware, but reassured","volume":"20","author":"Beltrami-Moreira","year":"2022","journal-title":"Clin Adv Hematol Oncol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.066_b0070","article-title":"COVID-19 vaccination associated severe immune thrombocytopenia","volume":"10","author":"Shah","year":"2021","journal-title":"Exp Hematol Amp Oncol"},{"issue":"10","key":"10.1016\/j.vaccine.2023.04.066_b0075","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood.2021013411","article-title":"SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP","volume":"139","author":"Lee","year":"2022","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.vaccine.2023.04.066_b0080","doi-asserted-by":"crossref","first-page":"3329","DOI":"10.1016\/j.vaccine.2021.04.054","article-title":"Thrombocytopenia including immune thrombocytopenia after receipt of mRNA COVID-19 vaccines reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"39","author":"Welsh","year":"2021","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2023.04.066_bib102","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1007\/s00277-023-05136-2","article-title":"Analysis of hematologic adverse events reported to a national surveillance system following COVID-19 bivalent booster vaccination","volume":"102","author":"Jacobs","year":"2023","journal-title":"Ann Hematol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.066_bib103","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/bjh.18627","article-title":"Autoimmune haemolytic anaemia and immune thrombocytopenia following SARS-CoV-2 and non-SARS-CoV-2 vaccination: 32\u2009Years of passive surveillance data","volume":"201","author":"Jacobs","year":"2023","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.vaccine.2023.04.066_b0085","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1053\/j.seminhematol.2022.03.002","article-title":"Treatment of vaccine-induced immune thrombotic thrombocytopenia (VITT)","volume":"59","author":"Gabarin","year":"2022","journal-title":"Semin Hematol"},{"issue":"1","key":"10.1016\/j.vaccine.2023.04.066_b0090","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1016\/S2352-3026(21)00306-9","article-title":"Vaccine-induced immune thrombotic thrombocytopenia","volume":"9","author":"Klok","year":"2022","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.vaccine.2023.04.066_b0095","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.ijid.2022.03.034","article-title":"Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia: A Systematic Review and Meta-Analysis","volume":"119","author":"Kim","year":"2022","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.vaccine.2023.04.066_b0100","unstructured":"COVID-19 Vaccination. (2020, February 11). Centers for Disease Control and Prevention. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/adverse-events.html."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23004905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:26:57Z","timestamp":1759404417000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23004905"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":22,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S0264410X23004905"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hematologic adverse events reported after COVID-19 vaccination in the Philippines: A national database study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.04.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}